14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 ATOS stock ended at $1.72. This is 3.61% more than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 6.53% from a day low at $1.67 to a day high of $1.78.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Atossa Genetics Inc. prices

Date Open High Low Close Volume
Jan 20, 2022 $1.36 $1.43 $1.30 $1.31 2 209 300
Jan 19, 2022 $1.40 $1.43 $1.32 $1.35 2 379 200
Jan 18, 2022 $1.43 $1.47 $1.38 $1.39 1 780 000
Jan 14, 2022 $1.39 $1.48 $1.38 $1.46 1 709 400
Jan 13, 2022 $1.48 $1.52 $1.40 $1.41 1 801 600
Jan 12, 2022 $1.56 $1.57 $1.48 $1.49 1 871 500
Jan 11, 2022 $1.51 $1.60 $1.50 $1.54 1 798 500
Jan 10, 2022 $1.52 $1.52 $1.45 $1.50 2 007 500
Jan 07, 2022 $1.57 $1.62 $1.52 $1.53 1 795 800
Jan 06, 2022 $1.60 $1.61 $1.49 $1.53 2 437 500
Jan 05, 2022 $1.71 $1.74 $1.56 $1.56 3 273 235
Jan 04, 2022 $1.74 $1.80 $1.69 $1.72 2 195 135
Jan 03, 2022 $1.63 $1.78 $1.59 $1.74 3 561 143
Dec 31, 2021 $1.65 $1.70 $1.59 $1.60 3 319 669
Dec 30, 2021 $1.60 $1.72 $1.59 $1.66 3 347 251
Dec 29, 2021 $1.65 $1.67 $1.57 $1.60 4 144 249
Dec 28, 2021 $1.68 $1.76 $1.64 $1.66 4 553 362
Dec 27, 2021 $1.79 $1.80 $1.68 $1.70 4 637 805
Dec 23, 2021 $1.85 $1.85 $1.77 $1.80 3 494 838
Dec 22, 2021 $1.84 $1.87 $1.81 $1.84 2 332 109
Dec 21, 2021 $1.91 $1.92 $1.85 $1.86 2 961 389
Dec 20, 2021 $1.88 $1.93 $1.84 $1.87 2 240 518
Dec 17, 2021 $1.90 $1.97 $1.82 $1.97 3 019 507
Dec 16, 2021 $2.00 $2.02 $1.89 $1.90 2 380 557
Dec 15, 2021 $1.90 $2.00 $1.84 $1.97 3 237 925
Click to get the best stock tips daily for free!

About Atossa Genetics Inc.

Atossa Genetics Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien... ATOS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT